» Articles » PMID: 38517886

Evolution of Chromosome-arm Aberrations in Breast Cancer Through Genetic Network Rewiring

Abstract

The basal breast cancer subtype is enriched for triple-negative breast cancer (TNBC) and displays consistent large chromosomal deletions. Here, we characterize evolution and maintenance of chromosome 4p (chr4p) loss in basal breast cancer. Analysis of The Cancer Genome Atlas data shows recurrent deletion of chr4p in basal breast cancer. Phylogenetic analysis of a panel of 23 primary tumor/patient-derived xenograft basal breast cancers reveals early evolution of chr4p deletion. Mechanistically we show that chr4p loss is associated with enhanced proliferation. Gene function studies identify an unknown gene, C4orf19, within chr4p, which suppresses proliferation when overexpressed-a member of the PDCD10-GCKIII kinase module we name PGCKA1. Genome-wide pooled overexpression screens using a barcoded library of human open reading frames identify chromosomal regions, including chr4p, that suppress proliferation when overexpressed in a context-dependent manner, implicating network interactions. Together, these results shed light on the early emergence of complex aneuploid karyotypes involving chr4p and adaptive landscapes shaping breast cancer genomes.

Citing Articles

Aneuploidy as a driver of human cancer.

Sdeor E, Okada H, Saad R, Ben-Yishay T, Ben-David U Nat Genet. 2024; 56(10):2014-2026.

PMID: 39358600 DOI: 10.1038/s41588-024-01916-2.


Prognostic importance of splicing-triggered aberrations of protein complex interfaces in cancer.

Newaz K, Schaefers C, Weisel K, Baumbach J, Frishman D NAR Genom Bioinform. 2024; 6(3):lqae133.

PMID: 39328266 PMC: 11426328. DOI: 10.1093/nargab/lqae133.


Patterns of Aneuploidy and Signaling Consequences in Cancer.

Zhakula-Kostadinova N, Taylor A Cancer Res. 2024; 84(16):2575-2587.

PMID: 38924459 PMC: 11325152. DOI: 10.1158/0008-5472.CAN-24-0169.


Dynamics of karyotype evolution.

Kuzmin E, Baker T, Van Loo P, Glass L Chaos. 2024; 34(5.

PMID: 38717409 PMC: 11068413. DOI: 10.1063/5.0206011.


Inferring chromosomal instability from copy number aberrations as a measure of chromosomal instability across human cancers.

Taluri S, Oza V, Soelter T, Fisher J, Lasseigne B Cancer Rep (Hoboken). 2023; 6(12):e1902.

PMID: 37680168 PMC: 10728508. DOI: 10.1002/cnr2.1902.


References
1.
Ceccarelli D, Laister R, Mulligan V, Kean M, Goudreault M, Scott I . CCM3/PDCD10 heterodimerizes with germinal center kinase III (GCKIII) proteins using a mechanism analogous to CCM3 homodimerization. J Biol Chem. 2011; 286(28):25056-64. PMC: 3137079. DOI: 10.1074/jbc.M110.213777. View

2.
Paysan-Lafosse T, Blum M, Chuguransky S, Grego T, Pinto B, Salazar G . InterPro in 2022. Nucleic Acids Res. 2022; 51(D1):D418-D427. PMC: 9825450. DOI: 10.1093/nar/gkac993. View

3.
Stephens P, Tarpey P, Davies H, Van Loo P, Greenman C, Wedge D . The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012; 486(7403):400-4. PMC: 3428862. DOI: 10.1038/nature11017. View

4.
Minussi D, Nicholson M, Ye H, Davis A, Wang K, Baker T . Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature. 2021; 592(7853):302-308. PMC: 8049101. DOI: 10.1038/s41586-021-03357-x. View

5.
Zhang S, Wu H, Wang K, Liu M . STK33/ERK2 signal pathway contribute the tumorigenesis of colorectal cancer HCT15 cells. Biosci Rep. 2019; 39(3). PMC: 6395305. DOI: 10.1042/BSR20182351. View